Epidemiology of Tuberculosis and BCG vaccine uptake among Pasifika in Aotearoa New Zealand

Masters Scholarship
RHONITA SCHUTZ

 

People Leadership v5
Principal Investigator
Rhonita Schutz
Auckland University of Technology
Public Contact
Kim Thomas
teniwhacomms@otago.ac.nz
Project Timeframe/Status
-
In Process

Te Reo Here Summary of Research

Tuberculosis (TB) has many known risk factors that allow persistence in many countries, particularly developing countries in the Pacific. Aotearoa New Zealand as a high-income country by World Bank standards is fortunate to have low incidence rate of 6.3 per 100,000. However, TB incidence is more common in particular ethnic groups of the population. The Pasifika population in New Zealand exhibit unique set of vulnerabilities that increase susceptibility to the disease due to two main factors. The first is the fluid movement to neighbouring Pacific Island countries that have higher TB prevalence, which can increase exposure to TB. This can result in Latent TB infection (LTBI) or active TB. The second factor that contributes to Pasifika vulnerability is the high prevalence of both communicable and non-communicable diseases in the communities (and social determinants of health that influence these disease rates, such as, housing and access to appropriate health care) that increases the risk of LTBI activation to active TB.  

 

 

There is one licensed vaccine widely used to prevent TB called the Bacillus Calmette–Guérin BCG. The World Health Organisation recommends BCG inclusion in neonatal vaccination schedules, depending on the TB epidemiology of the country. Many high prevalence countries in the Pacific have been recommended to administer one dose to all neonates. However, low prevalence countries, such as New Zealand, can focus vaccination on high risk groups only, through recommendation by healthcare professionals to parents. Recommendation is based on specific eligibility criteria, meaning that Pasifika children born in New Zealand are not necessarily entitled to BCG vaccination. Considering their unique set of vulnerabilities, this is a disadvantage for the Pasifika population. Therefore, this study aims to inform improvements to the BCG vaccination programme in New Zealand, and to TB prevention efforts in general, to reduce TB disease burden among the Pasifika population for more equitable outcomes. This will be achieved through a mixed methods study involving a quantitative observational study and a qualitative interpretive descriptive study. The overall study will draw from a Pasifika research worldview, utilizing Te Kora as a framework.

 

Te Reo Here Research Impact

The overall study will draw from a Pasifika research worldview for both quantitative and qualitative components, utilizing Te Kora as a framework, which is based on the Kiribati cultural practice of making local string. As the study will focus on the Pasifika population, the framework is important to include Pasifika worldview to steer the study that aligns with the values of respect and compassion, as well as unity, in order to incorporate cultural appropriateness at each step. Te Kora framework consist of six phases based on the six main steps of making Kora (local string). This includes the initial scoping for the project and relationship building, data collection, transcription and translation, familiarization and summary, data analysis, and findings presented as a thesis which will be shared to Pasifika key-informants and communities.

Data collection for the qualitative component will utilise maroro (conversation), with 3-4 senior TB key informants for BCG immunisation policies and programmes in Aotearoa New Zealand. Maroro is similar to the research tool talanoa, in the sense that it is used to remove barriers between participant and the researcher. This is important in Pasifika cultural customs as it removes any form of hierarchy for the researcher, particularly during conversations with seniors/elders. This creates an open and free environment to share personal experiences which produces ‘karaki’ (stories) as data. This can benefit participants by providing a platform where they can share the process and scope of decision-making that allow protection of the New Zealand population from tuberculosis. 

 

Cultural considerations include the phases being steered by the three main principles of Kiribati cultural etiquette which are always applied to the process of making kora. The study also incorporates Te Niwha principles of research, which are underpinned by Te Tirity o Waitangi, and ensure obligations to Te Tiriti: 

1. Bauariria (accountability)
“Bau” means vow; “Ariria” means to tighten Bauariria aligns with Te Niwha principles Tiakitanga/accountability to the Pasifika communities which our data will derive from. Data sovereignty, collection and handling of data will also be integrated and considered under the guidance of supervisor Dr Taniela Lolohea.  

2. Kaomataaki (consultations)
“Kao” to invite, “Aomataaki” to make certain of the person. Kaomataaki will ensure integrity and collaboration values, by endorsing the projects’ aim and objectives, especially with presenting findings to Pasifika communities and leaders/stakeholders, who can utilise the findings to inform improvements for neonatal BCG uptake for Pasifika. This will ensure Pasifika leadership for this important work. 

3. Iokinibwai (reciprocity)
“Ioki” exchange of goods, food, or services and also referred to ‘reconciliation’, “Bwai” means things. Iokinibwai also aligns with Te Niwha principles of partnership (Tūhonotanga) and relationships (Hononga), as it will ensure a healthy relationship that is positively impactful for Pasifika communities.   

Te Niwha

Te Reo Here Research Personnel

Dr Nadia Charania
Auckland University of Technology | Supervisor
 
Dr Janine Paynter
University of Auckland | Supervisor
 
Dr Taniela Lolohea
Auckland University of Technology | Supervisor